APTO
Price
$0.21
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
12.54M
ORMP
Price
$2.28
Change
-$0.04 (-1.72%)
Updated
Jan 17 closing price
Capitalization
91.91M
39 days until earnings call
Ad is loading...

APTO vs ORMP

Header iconAPTO vs ORMP Comparison
Open Charts APTO vs ORMPBanner chart's image
Aptose Biosciences
Price$0.21
Change-$0.00 (-0.00%)
Volume$264.33K
Capitalization12.54M
Oramed Pharmaceuticals
Price$2.28
Change-$0.04 (-1.72%)
Volume$137.56K
Capitalization91.91M
APTO vs ORMP Comparison Chart
Loading...
APTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APTO vs. ORMP commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APTO is a Hold and ORMP is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (APTO: $0.21 vs. ORMP: $2.28)
Brand notoriety: APTO and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APTO: 3% vs. ORMP: 80%
Market capitalization -- APTO: $12.54M vs. ORMP: $91.91M
APTO [@Biotechnology] is valued at $12.54M. ORMP’s [@Biotechnology] market capitalization is $91.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APTO’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • APTO’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than APTO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APTO’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 2 bullish TA indicator(s).

  • APTO’s TA Score: 4 bullish, 3 bearish.
  • ORMP’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, APTO is a better buy in the short-term than ORMP.

Price Growth

APTO (@Biotechnology) experienced а -2.77% price change this week, while ORMP (@Biotechnology) price change was -4.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

APTO is expected to report earnings on Aug 10, 2023.

ORMP is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($91.9M) has a higher market cap than APTO($12.5M). APTO YTD gains are higher at: -5.060 vs. ORMP (-5.785). ORMP has higher annual earnings (EBITDA): 9.44M vs. APTO (-35.78M). ORMP has more cash in the bank: 142M vs. APTO (2.9M). ORMP has less debt than APTO: ORMP (429K) vs APTO (10.7M). APTO (0) and ORMP (0) have equivalent revenues.
APTOORMPAPTO / ORMP
Capitalization12.5M91.9M14%
EBITDA-35.78M9.44M-379%
Gain YTD-5.060-5.78587%
P/E RatioN/A20.73-
Revenue00-
Total Cash2.9M142M2%
Total Debt10.7M429K2,494%
FUNDAMENTALS RATINGS
APTO vs ORMP: Fundamental Ratings
APTO
ORMP
OUTLOOK RATING
1..100
8868
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10085
PRICE GROWTH RATING
1..100
6556
P/E GROWTH RATING
1..100
10055
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (66) in the Pharmaceuticals Other industry is in the same range as APTO (90) in the Biotechnology industry. This means that ORMP’s stock grew similarly to APTO’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as APTO (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to APTO’s over the last 12 months.

ORMP's SMR Rating (85) in the Pharmaceuticals Other industry is in the same range as APTO (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to APTO’s over the last 12 months.

ORMP's Price Growth Rating (56) in the Pharmaceuticals Other industry is in the same range as APTO (65) in the Biotechnology industry. This means that ORMP’s stock grew similarly to APTO’s over the last 12 months.

ORMP's P/E Growth Rating (55) in the Pharmaceuticals Other industry is somewhat better than the same rating for APTO (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than APTO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APTOORMP
RSI
ODDS (%)
Bullish Trend 5 days ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 5 days ago
80%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
78%
MACD
ODDS (%)
N/A
Bearish Trend 5 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
68%
Bearish Trend 5 days ago
83%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
75%
N/A
View a ticker or compare two or three
Ad is loading...
APTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

APTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, APTO has been loosely correlated with LCTX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if APTO jumps, then LCTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APTO
1D Price
Change %
APTO100%
+3.33%
LCTX - APTO
35%
Loosely correlated
+2.80%
AADI - APTO
32%
Poorly correlated
-4.79%
ATNM - APTO
26%
Poorly correlated
+14.75%
HUMA - APTO
26%
Poorly correlated
-1.56%
ORMP - APTO
25%
Poorly correlated
-1.72%
More

ORMP and

Correlation & Price change

A.I.dvisor tells us that ORMP and XERS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORMP and XERS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-1.72%
XERS - ORMP
30%
Poorly correlated
-0.62%
AKBA - ORMP
29%
Poorly correlated
+7.25%
FULC - ORMP
28%
Poorly correlated
-0.50%
INZY - ORMP
28%
Poorly correlated
N/A
PRLD - ORMP
27%
Poorly correlated
+2.94%
More